Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Healthy male and female subjects ages 18 to 49 years, inclusive. * Women of childbearing potential must be using an acceptable method of contraception for at least 4 weeks prior to study drug administration. Exclusion Criteria: * Any significant acute or chronic medical illness * Current or recent (within 3 months of study drug administration) gastrointestinal disease * Any gastrointestinal surgery that could impact upon the absorption of study drug, including cholecystectomy * History of biliary disorders, including Gilbert's syndrome or Dubin-Johnson disease * Use of tobacco-containing or nicotine-containing products * Any of the following on 12-lead electrocardiogram (ECG) prior to study drug administration, confirmed by repeat: * PR ≥210 msec * QRS ≥120 msec * QT ≥500 msec * QTcF ≥450 msec * Any of the following laboratory results outside of the ranges specified below prior to study drug administration, confirmed by repeat: * Alanine aminotransferase (ALT) \>Upper limit of normal (ULN) * Aspartate aminotransferase (AST) \>ULN * Total bilirubin (TBILI) \>ULN * Creatinine \>ULN